Subject: MJNA's Kannaway® Revenue has Grown Steeply Beginning March 2016

SCV Client Spotlight
BY READING THIS EMAIL YOU CERTIFY YOU HAVE READ THE DISCLAIMER BELOW AND THE FULL DISCLAIMER PROVIDED THROUGH A LINK AT THE END OF THIS EMAIL. This is a paid advertisement. SmallCapVoice.com, Inc. is not responsible or held liable for the information in the press releases issued by the companies in these emails. Please always do your own due diligence.
Facebook Twitter YouTube
MJNA's Kannaway® Revenue has Grown Steeply Beginning March 2016
Hot Stock to WatchHot Stock to Watch

Company: Medical Marijuana, Inc. (Pink Sheets: MJNA)


Last:

Price: 0.112

Change (%): + 0.00 (0.00)

Volume: 2,523,933
MJNA Chart

Medical Marijuana, Inc. Subsidiary Kannaway® Announces July 25, 2017 Largest Revenue Day in Company History

First Hemp Lifestyle Network to Offer CBD Products Announces Largest Sales Day Since Company Was Founded

SAN DIEGO, Aug. 1, 2017 /PRNewswire/ - Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis company in the United States, today announced that its subsidiary Kannaway® achieved the largest revenue in a single day on July 25, 2017, in the Company’s history. Kannaway® is the first hemp lifestyle network to offer cannabidiol (CBD) hemp botanical products.

“Kannaway®’s revenue has grown steeply beginning March 2016 to date. Kannaway® celebrated the largest revenue month in its history in June, and we believe July revenues will surpass our June performance,” said Kannaway® CEO Blake Schroeder. “We look forward to setting new revenue performance records as our company continues to grow and enter new markets. We are especially excited about Kannaway®’s European expansion set for Q4, 2017.”

Recognizing that the success of Kannaway® brand ambassadors is a key part of the Company’s mission, the Company has initiated several programs to recognize top performers that include special trip and prize incentives and an innovative stock incentive program.

Continue Reading

Like Us on FacebookFollow Us on Twitter

IMPORTANT DISCLAIMER - PLEASE READ THOROUGHLY
SmallCapVoice (SCV) is an electronic publication. Information sources for our profiles include, but are not limited to, online research, member suggestions, magazines, newspapers, analyst suggestions, publicly available material information provided by the profiled company, press releases and similar sources. This communication is not an offer to sell or a recommendation that you buy or sell any security. SCV holds no securities licenses and is not qualified to provide investment advice. We are compensated for these advertisements by the profiled companies. You should not use this newsletter as the sole basis for any investment decision. While all investments involve risk, microcap stocks are among the most risky. Many microcap companies have no proven track record. You should only invest in microcap companies if you can afford to lose your entire investment. You should consult a qualified, licensed financial advisor or stock broker before making any decisions to invest in the securities of any company that is described in these profiles. These profiles are paid advertisements. Although we have a reasonable belief that the information in each profile is accurate, we cannot guarantee that this information, which originates from third parties, is accurate. We do not have the resources to confirm the accuracy of all information obtained from third parties. It is important for you to verify all information by your own independent research. You are receiving this message because you have agreed to receive emails from SmallCapVoice.com. You may opt out of our distribution list at any time by clicking on the “unsubscribe” link below. Link to full disclosure about compensation paid to SmallCapVoice.com, Inc. by companies featured on our website or in our e-mail communications.

About Penny Stocks